期刊文献+

起搏治疗遗传性长QT间期综合征23例 被引量:3

Treatment of congenital Iong QT syndrome with permanent cardiac pacing
暂未订购
导出
摘要 目的:评价VVI起搏治疗遗传性长QT综合征的疗效。方法:对23例有尖端扭转性室速发作,且经正规药物治疗无效或无法耐受的遗传性长QT综合征患者,植入了VVI起搏器。随访这23例患者术后心电图及心脏事件发生率。结果:QT间期平均值由术前(638.0±55.7)ms缩短至术后的(471.3±48.9)ms,QTc平均值为由0.627±0.07缩短至0.519±0.06。心脏事件的发生率由术前的(0.353±0.46)次/年降至术后(0.111±0.24)次/年,(P=0.039)。其中77.5%的患者随访期间无晕厥或猝死等心脏事件发生。90.91%患者存活。2例患者因尖端扭转性室速恶化为室颤抢救无效死亡。结论:VVI起搏治疗可以有效地减少长QT综合征患者恶性心律失常的发生,是治疗长QT综合征的重要方法之一。 Objective: To evaluate the efficacy of permanent cardiac-pacing for treatment in patients with congenital long QT syndrome, Methods:23 congenital long QT syndrome patients who oceured torsade de points and failed to respond or intolerable to drugs were implanted VVI permanent cardiac pacemakers. The electrocardiogram and heart events were observed after the pacemaker implantation. Results:After pacemaker implantation, average QT interval was shortened from (638.0±55.7)ms to (471.3 ± 48.9)ms (P=0. 00025), QTc interval from (0. 627± 0.07)ms to (0. 519± 0.06)ms (P=0. 00025) and the rate of recurrent cardiac events was significantly reduced from 0. 353 ±0.46/yr to 0. 111 ± 0.24/yr (P=0. 039). During follow up, 90.91% patients were alive, 77.5% patients had no cardiac events occurred and 2 patients died of TDP. Conclusions: Permanent VVI cardiac-pacing is one of the effective methods in the treatment of congenital LQTS patients by reducing malignant arrhythmia.
出处 《国际心血管病杂志》 2006年第5期349-351,共3页 International Journal of Cardiovascular Disease
关键词 长QT综合征 尖端扭转性室速 VVI起搏器 Long QT syndrome Torsade de points VVI permanent cardiac pacemake
  • 相关文献

参考文献10

  • 1[1]Roden DM,Lazzare R,Rosen M.Multiple mechanisms in the long QT syndrome:current knowledge,gaps and future directions.The SADS Foundation Task Force on LQTS[J].Circulation,1996,94(8):1996-2012
  • 2[2]Viskin S.Long QT syndromes and torsade de pointes[J].Lancet,1999,354(9190):1625-1633.
  • 3[3]Schewartz PJ.Idiopathic long QT syndrome:progress and questions[J].Am Heart J,1985,109(2):399-411.
  • 4[4]Viskin S Cardiac pacing in the long QT syndrome:review of available data and practical recommendations[J].J Cardiovasc Electrophysiol,2000,11(5):593-600.
  • 5[5]Monnig G,Kobe J,Loher A.Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome:a long-term follow-up[J].Heart Rhythm,2005,2(5):497-504.
  • 6[6]Viskins,Fish R,Zeltser D.Arrythmias in the congenital long QT syndrome:how often is torsade de pointes pausedependent[J].Heart,2000,83(6):661-666.
  • 7[7]7 Viskin S,Alla SR,Barron HV.Mode of onset of torsade de pointes in congenital long QT syndrome[J].J Am Coll Cardiol,1996,28(5):1262-1268.
  • 8[8]Tan HD,Hou CJ,Lower MR.Electrophysiologic mechanisms of the long QT syndromes and torsade de pointes[J].Ann Intern Med,1995,122(9):704-714.
  • 9[9]Locati EH,Maison-Blanche P,Dejode P,et al.Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization:uantitative analysis of Holter recordings[J].J Am Coll Cardiol,1995,25(7):1564-1575.
  • 10[10]Hirao M,Shimizu W,Knrita T,et al.Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome[J].J Am Coll Cardiol,1996,28(5):1269-1277.

同被引文献39

  • 1张海澄,易忠,郭继鸿,王方正.中华医学会心电生理和起搏分会第六届学术双年会会议纪要(心脏起搏部分)[J].中华心律失常学杂志,2005,9(1):76-78. 被引量:4
  • 2蒋文平,杨向军.胺碘酮应用指南解读[J].中国心脏起搏与心电生理杂志,2005,19(1):16-18. 被引量:68
  • 3汪明慧,梁文同,沐贤友.长QT综合征的临床特点和治疗进展[J].国外医学(内科学分册),2006,33(1):4-6. 被引量:4
  • 4Lau CP,Tse HF,Yu CM,et al.Dual-site atrial pacing for atrial fibrillation in patients without bradycardia[J].AM J Cardiol,2001,88:371.
  • 5W A NG L X.Implantable cardiover defibrillator therapy:the state of the art and future perspectives[J].Indian Heart Joumal,2002,54:672-675.
  • 6MOSS A J,ZAREBA W,HALL W J,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection farction.The multicenter automatic aefibrillator implantation trial Ⅱ investigators[J].N Engl J Med,2002,346:877-883.
  • 7The AVID Investigators.A comparison of antiarrhythmic drug therapy with implantable cardioverter-defibrillators in patients resuscitated from near-fatal ventricular arrhythmias[J].N Engl J Med,1997,337:1576-1583.
  • 8CCONNOLLY S I,GENT M,ROBERTS R S,et al.Canadian implantable defibrillator study(CIDS):a random ized trial of implantable cardioverter defibrillator against am iodarone[J].Circulation,2000,101:1297-1303.
  • 9KUCK K H,CAPPATO R,SIEBELS J,et al.Random ized companison of antiarrhythmic drug the rapy-with implantable cardioverter-defibrillators in patients resuscitated from cardiac arrest:the cardiac arrest study hamburg(CASH)[J].Circulation,2000,102:748-754.
  • 10Connolly SJ,Sheldon RS,Roberts RS,et al.The North American Vasovagal Pacemaker Study:a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope[J].J Am Coll Cardiol,1999,33:16-20.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部